Related Experiment Videos

Effects of basic fibroblast growth factor on the retinal degeneration of the mi(vit)/mi(vit) (vitiligo) mouse: a

S B Smith1, R Titelman, D I Hamasaki

  • 1Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta 30912-2000, USA.

Experimental Eye Research
|November 1, 1996
PubMed

Insights

Basic fibroblast growth factor (bFGF) did not protect photoreceptor cells in vitiligo mice. Unlike in RCS rats, bFGF injections worsened retinal degeneration and did not improve electrophysiological function in this model.

Area of Science:

  • Ophthalmology
  • Retinal Degeneration Research
  • Cell Biology

Background:

  • Photoreceptor cell death is a hallmark of several retinal diseases.
  • Basic fibroblast growth factor (bFGF) has shown neuroprotective effects in some models of retinal degeneration, notably the RCS rat.
  • The vitiligo mouse model exhibits slow photoreceptor cell loss due to a defect in the retinal pigment epithelium (RPE).

Purpose of the Study:

  • To investigate the efficacy of intravitreal bFGF injections in preventing photoreceptor cell death in the vitiligo mouse model.
  • To assess the impact of bFGF on retinal electrophysiology and histology in vitiligo mice.

Main Methods:

  • Vitiligo mice received intravitreal injections of bFGF (with or without heparin) or vehicle at various ages.
  • Scotopic electroretinograms (ERGs) were recorded.
  • Eyes were analyzed histologically at different time points post-injection.

Main Results:

  • bFGF injections, particularly without heparin, led to increased photoreceptor cell death and subretinal space infiltration by macrophages.
  • ERG b-wave amplitudes were significantly reduced in bFGF-injected eyes compared to controls.
  • Histology showed no significant difference in photoreceptor cell counts, though heparin co-administration showed minor improvements in outer segment attachment.

Conclusions:

  • Intravitreal bFGF does not appear to be neuroprotective in the vitiligo mouse model of retinal degeneration.
  • bFGF administration, especially without heparin, may exacerbate retinal damage in this model.
  • The therapeutic effect of bFGF observed in RCS rats is not replicated in the vitiligo mouse model, suggesting model-specific responses.

Related Concept Videos